Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 8/20 | 0.35 |
| ▸ | DPP8 | Q6V1X1 | 3/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 2/20 | 0.35 |
| ▸ | FAP | Q12884 | 1/20 | 0.35 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.35 |
| ▸ | PARP1 | P09874 | 2/20 | 0.34 |
| ▸ | HTR2C | P28335 | 2/20 | 0.33 |
| ▸ | HTR2B | P41595 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | ANPEP | P15144 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.31 |
| ▸ | NOS3 | P29474 | 1/20 | 0.31 |
| ▸ | NOS1 | P29475 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9803421 | 0.94 | DPP4 (0.37) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL1114767 | 0.78 | DPP4 (0.34) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL5699875 | 0.78 | DPP4 (0.34) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL720328 | 0.78 | DPP4 (0.34) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL5689235 | 0.77 | DPP4 (0.36) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL9194164 | 0.77 | DPP4 (0.36) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL4963191 | 0.77 | DPP4 (0.41) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL444869 | 0.75 | DPP4 (0.42) | DPP4DPP8DPP9FAPDPP7 | |
| SCHEMBL4961794 | 0.72 | SMN1; SMN2 (0.38) | — | |
| SCHEMBL27661363 | 0.72 | SMN1; SMN2 (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2401610-A1 | METHODS FOR IDENTIFICATION | Cambridge Enterprise Ltd. (GB) | 2012-01-04 | — | — | EP | disclosed |
| WO-2010097591-A1 | METHODS FOR IDENTIFICATION | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2010-09-02 | — | — | WO | disclosed |
| EP-1896036-A1 | ANTI-INFLAMMATORY AGENTS | Cambridge Enterprise Limited (GB) | 2008-03-12 | — | — | EP | disclosed |
| WO-2006134384-A1 | ANTI-INFLAMMATORY AGENTS | CAMBRIDGE ENTERPRISE LIMITED (GB) | 2006-12-21 | — | — | WO | disclosed |